Category: Conceptus Inc.
If you read nothing else today, make sure you're still in the know with MassDevice +3 for April 29, 2013.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Medical device company Conceptus agrees to a $1.1 billion buyout by German healthcare conglomerate Bayer AG.
Conceptus (NSDQ:CPTS) agreed to a buyout by Bayer (PINK:BAYRY) in a deal valued at $1.1 billion.
Shares of medical device company Conceptus hit a 52-week high on its swing to profitability from 4th-quarter and annual losses.
Conceptus (NSDQ:CPTS) shares hit a yearlong high last week after the medical device company swung from red ink to black for the 4th quarter and 2012.
Conceptus posts 3Q net income, reversing losses from the same period last year.
Conceptus (NSDQ:CPTS) touted a Q3 return to the black, back from previous losses reporting for the same period last year.
The Mountain View medical device maker posted $2.3 million net income, or 7¢ per share, on sales of $35.5 million. That compared with net loss of $2.9 million, or 9¢ per share, during the same period last year.
Sam Trujillo, executive VP of marketing at medical device company Conceptus, is leaving the firm.
After a year and 9 months on the job at Conceptus (NSDQ:CPTS), executive vice president of marketing Sam Trujillo is leaving the position that was created for him.
Conceptus' new chief commercial officer and executive vice president David Chung spent 15 years in different sales, marketing and operations roles at Edwards Lifesciences.
Conceptus hires former Edwards employee
